These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24576935)

  • 21. [Osteoporosis--new therapeutic possibilities. The Danish Bone Society].
    Langdahl BL; Rejnmark L;
    Ugeskr Laeger; 2008 Mar; 170(12):1043. PubMed ID: 18397661
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect and role of teriparatide in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug selection guide for osteoporosis determined by the clinical staging, pathophysiology and age].
    Tanaka I; Oshima H
    Nihon Rinsho; 2009 May; 67(5):915-20. PubMed ID: 19432109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Secondary osteoporosis UPDATE. Pathophysiology and management of cancer treatment-induced bone loss/fractures].
    Yoneda T
    Clin Calcium; 2010 May; 20(5):690-9. PubMed ID: 20445280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contemporary diagnostics and therapy of osteoporosis].
    Vogel T; Bitterling H; Dobler T; Bartl R; Pfeifer KJ; Mutschler W
    Zentralbl Chir; 2006 Oct; 131(5):401-6. PubMed ID: 17089289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of evidence-based principles of care in older persons (issue 1): management of osteoporosis.
    Zarowitz BJ; Stefanacci R; Hollenack K; O'Shea T
    J Am Med Dir Assoc; 2007 Mar; 8(3 Suppl 2):e51-7. PubMed ID: 17352989
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bone diseases with Pain. Osteoporosis].
    Hayashi Y
    Clin Calcium; 2007 Apr; 17(4):606-12. PubMed ID: 17404492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of primary osteoporosis in men].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
    Delmas PD; Eastell R; Garnero P; Seibel MJ; Stepan J;
    Osteoporos Int; 2000; 11 Suppl 6():S2-17. PubMed ID: 11193237
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical markers in osteoporosis: usefulness in clinical practice.
    Romero Barco CM; Manrique Arija S; Rodríguez Pérez M
    Reumatol Clin; 2012; 8(3):149-52. PubMed ID: 22089065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
    Iwamoto J
    Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis at presentation of childhood ALL: management with pamidronate.
    Goldbloom EB; Cummings EA; Yhap M
    Pediatr Hematol Oncol; 2005; 22(7):543-50. PubMed ID: 16166046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
    Fukunaga M; Sone T
    Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of transient osteoporosis with intravenous zoledronate: a case report.
    Maslin D; Karanth M; Bhagat S; Guirguis R
    Int J Rheum Dis; 2014 Sep; 17(7):816-7. PubMed ID: 24673857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.